The score is not available for this stock. This could be because (a) the market cap of the... Read More
Value score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
Price Momentum score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
QVM score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
GENPHARMA Key Metrics
GENPHARMA Share Price
Stock Analysis
Snapshot
Shareholding Pattern
Bulk, Block & Insider Trades
Corporate Actions
Company Profile
GENPHARMA Share Price
GENPHARMA
1 Week returns: -
1 Month returns: -
1 Year returns: -
3 Years CAGR: -
5 Years CAGR: -
Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
GENPHARMA Stock Analysis
Views
Red Flags
Positive
Strong revenue growth and above median growth of industry
Negative
Expensive and at a premium to industry median P/E
Low but stable ROE
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Low operating margin but improving trend
Low Debt to Equity but increasing
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.05499.
Snapshot
See detailed analysis
GENPHARMA Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
GENPHARMA Bulk, Block & Insider Trades
GENPHARMA Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
Rights issue
Stock split
Others
Rights issue(1 new shares @ 1.75 INR for 1 existing shares)"Rights ISIN INE861N20010 CINS Y2S17G104 SEDOL BPQWK82." Ex-date: 9th Jan 2024 Announced on: 3rd Jan 2024
Stock split(1 : 10)Nominal value change From INR.10.00 to 1.00. Ex-date: 11th Apr 2019 Announced on: 28th Feb 2019
Capital Reduction (CRD)Shares reduced from 6519700 to 325985. Ex-date: 3rd Aug 2016 Announced on: 19th Jul 2016
Company Profile
Genpharmasec Limited is an India-based company, which is engaged in the distribution of diagnostic pharma equipment and trading of securities. The Company’s segments include Pharmaceuticals, Trading in Securities, and Laboratory Testing. The Trading in Securities segment invests in the secondary sec... Read More
Key personnel
Mr. Sohan ChaturvediD
Chief Financial Officer, Whole Time Director
Mr. Hardik Makwana
Chief Compliance Officer, Whole Time Company Secretary
Mr. Rajesh Mirchumal SadhwaniD
Non-Executive Non Independent Director
Mrs. Sneha SadhwaniD
Non-Executive Non-Independent Director
Mr. Siddhesh ShendeD
Non-Executive Independent Director
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently Asked Questions about GENPHARMA
The current share price of Genpharmasec Ltd. is ₹ 1.13 as of 24 Jun 2026.
The Price-to-Earnings (PE) ratio of Genpharmasec Ltd. is 110.72 as of the latest financial data.
Genpharmasec Ltd. has a Return on Equity (ROE) of 0.85% and a Return on Capital Employed (ROCE) of -1.12% as per the latest financial reports.
The market capitalization of Genpharmasec Ltd. stands at ₹ 62.02 Cr.
The dividend yield of Genpharmasec Ltd. is 0.00% based on the current market price.
The Relative Strength Index (RSI) of Genpharmasec Ltd. is 41.81.
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.00% of Genpharmasec Ltd. shares.
Genpharmasec Ltd. operates in the Services sector.
The beta of Genpharmasec Ltd. stock is 1.10, indicating its volatility relative to the broader market.
